The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients
Crossref DOI link: https://doi.org/10.1038/s41598-022-07726-y
Published Online: 2022-03-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Jing
Zhang, Lin
Gou, Yuanyuan
Diao, Panya
Hu, Yi
Text and Data Mining valid from 2022-03-11
Version of Record valid from 2022-03-11
Article History
Received: 10 August 2021
Accepted: 17 February 2022
First Online: 11 March 2022
Competing interests
: The authors declare no competing interests.